Literature DB >> 34171408

The Serum SIRT1 Protein is Associated with the Severity of Injury and Neurological Recovery in Mice with Traumatic Spinal Cord Injury.

Guibin Zhong1, Yanqiu Yang2, Xiaodong Huang3, Junling Chen2, Daming Feng2, Ke Wei2, Jianwei Chen4, Haihong Chen5.   

Abstract

The present study aimed to investigate the association between the serum SIRT1 protein and the severity of spinal cord injury (SCI) as well as the neurological recovery in mice. In this study, the wild-type (WT), Mx1-Cre+ SIRT1loxP/loxP (Mx1), and LCK-Cre+SIRT1loxP/loxP (LCK) mice were subjected to sham surgery, mild, moderate, or severe SCI, respectively. The serum was collected at intervals of 12 h, 1 day (d), 3 d, 5 d, 7 d, 10 d, 14 d, and 21 d after the injury. The locomotor function of all the animals was assessed using the Basso mouse scale (BMS) and the serum SIRT1 proteins were analyzed using enzyme-linked immunosorbent assay (ELISA). The results demonstrated that about 7-10 d after SCI, the levels of SIRT1 protein in the serum correlated significantly with the severity of the injury and at 28 d post-injury, there was a distant neurological recovery (BMS score). The serum SIRT1 concentration in both the Mx1 and LCK mice in the sham group was significantly reduced compared to that in the WT mice, and there was a delayed increase in the serum SIRT1 levels after injury. These findings indicate that the SIRT1 concentrations in the serum of the SCI mice closely correlated with the acute severity and neurological outcome.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Basso mouse scale; SIRT1; functional recovery; traumatic spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 34171408     DOI: 10.1016/j.neuroscience.2021.06.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  1 in total

1.  Novel Injury Scoring Tool for Assessing Brain Injury following Neonatal Hypoxia-Ischemia in Mice.

Authors:  Burak Ozaydin; Ela Bicki; Onur E Taparli; Temour Z Sheikh; Danielle K Schmidt; Sefer Yapici; Margarett B Hackett; Nida Karahan-Keles; Jens C Eickhoff; Karson Corcoran; Claudia Lagoa-Miguel; Jose Guerrero Gonzalez; Douglas C Dean Iii; Andre M M Sousa; Peter A Ferrazzano; Jon E Levine; Pelin Cengiz
Journal:  Dev Neurosci       Date:  2022-05-25       Impact factor: 3.421

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.